Clinical Trial

OCD LIFU Target Engagement

Recruiting
View on ClinicalTrials.gov →
Summary
The investigators will conduct a pilot study to evaluate the safety and feasibility of low-intensity focused ultrasound on obsessive-compulsive disorder (OCD) symptoms when delivered to subcortical brain targets. The investigators will use the ATTN201 device to deliver single sessions of unfocused and focused ultrasound to up to three brain targets over 4 study visits and assess the intervention through self-rated scales of OCD symptoms.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-05-19 -> 2027-05-19 2026-07-25
minor Completion pushed: 2026-05-19 -> 2027-05-19 2026-07-25
Trial Details
NCT Number NCT07558148
Lead Sponsor University of Pennsylvania
Collaborators: Attune Neurosciences Inc
Conditions Obsessive Compulsive Disorder (OCD)
Enrollment 10 participants
Start Date 2026-03-04
Primary Completion 2027-05-19 (estimated)
Study Completion 2027-05-19 (estimated)
Updated on ClinicalTrials.gov 2026-07-24